Diagnostic Platform Entopsis offers OpsisDx, a universal platform for diagnosing cancer and various diseases via urine, presenting a direct sales opportunity to healthcare providers, laboratories, and clinics seeking non invasive diagnostic solutions.

Plant Testing The launch of PlantOpsis indicates a growth path in agricultural and plant health testing, creating cross‑sell opportunities with agritech firms, universities, and crop science labs looking for rapid, cost effective screening tools.

Cost Efficiency Emphasize the cost saving angles of PCRopsis and the broader screening platform to prospective customers in research labs and biotech service providers aiming to reduce time and expense in life sciences workflows.

Strategic Partnerships With a small team and modest revenue, there is potential to pursue channel partnerships, contract research organizations, and NI/academic collaborations to scale adoption of Entopsis technologies.

Future smartphone model Past efforts on smartphone based molecular profiling suggest opportunities for consumer health tech partnerships, telemedicine providers, and direct‑to‑consumer platforms seeking accessible at‑home diagnostics.